The global anticoccidial drugs market in animal health is expected to reach USD 24.33 billion by the year 2020..
Global Anticoccidial Drugs Market in Animal Health- Market Dynamics
In the veterinary antibiotic market, the market for food producing animals accounted for nearly 80% of the total market in 2011. This has increased the demand for anticoccidial drugs, largely due to the increased incidence of coccidiosis and other protozoan parasite based diseases that infect majorly food producing organisms but are not limited to them. In the poultry and cattle markets, the incidence of coccidiosis has cost millions of dollars in treatment and preventive care. Also, the trend of owning companion animals is also contributing to the increasing use of anticoccidials, as dogs, cats and occasionally even horses are prone to coccidiosis and if left untreated, it could lead to the death of the animal.
Some of the other factors driving this market are:
The global anticoccidial market has been segmented on the basis of animal type (poultry, cattle, swine, and companion animals), drugs (ionophore anticoccidials, chemical derivative anticoccidials, and antibiotic anticoccidials), and by geography (North America, Europe, Asia-Pacific and Rest of the World).
The Asia-Pacific region is set to be the largest contributor in terms of total revenue in this market by the year 2020. The countries set to be major contributors in this region are China, India, Japan, and Australia. The growth in the North American and European markets is set to be stagnant due to the stagnated market and government restrictions.
Some of the key players in the market are:
What the Report Offers